Business Telegraph

.

Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

  • Written by Telegraph Magazine

New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment

SINGAPORE - Media OutReach - 28 June 2023 – Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced the official opening of its latest Good Manufacturing Practice (GMP) facility in Singapore.

Read more: Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

More Articles ...

  1. Niigata Prefecture, center of Japanese culinary culture, hosts its first Gastronomy Awards
  2. The Industrial Development Bureau Joins Hands with the Institute for Information Industry
  3. ChainUp Joins "The Opportunities & Prospects of Virtual Asset in HK" Event Organized by Tencent Cloud
  4. Magna Markets release a set of tools that help newbie trade like a pro
  5. Hong Kong Investors Expanding Global Reach
  6. Oasys Announces Major Blockchain Gaming Updates, Featuring Leading Game Developers
  7. Schneider Electric honored with iF DESIGN AWARD and Red Dot Design Award with Miluz E switch series
  8. Winners of the Microsoft AI for Accessibility Hackathon 2023 showcase how inclusion is innovation in Asia Pacific
  9. OPPO Serves Up More Unparalleled Experiences through Professional Imaging Technologies at Wimbledon 2023
  10. Fulum FY2023 Annual Results Out of the Red